|
Market Closed -
Other stock markets
|
After hours 20:43:07 | |||
| 0.8900 EUR | +0.23% |
|
0.8890 | -0.11% |
| 06-10 | AB Science presents new data on Masitinib |  |
| 05-18 | AB Science S.A. announced that it has received $2.989368 million in funding | CI |
Projected Income Statement: AB Science
| Fiscal Period: December | 2020 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 1.583 | - | 0.97 | 1.072 | 1.174 | 1.2 | 1.3 |
| Change | - | - | - | 10.5% | 9.53% | 2.21% | 8.33% |
| EBITDA | - | - | -11.16 | -5.416 | - | - | - |
| Change | - | - | - | 51.46% | - | - | - |
| EBIT 1 | - | - | -13.43 | -6.083 | 0.639 | -6.5 | -6.4 |
| Change | - | - | - | 54.7% | 110.5% | -1,117.21% | 1.54% |
| Interest Paid 1 | - | - | - | - | -2.196 | -1 | -1 |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - |
| Net income | - | -13.62 | -10.05 | -7.831 | - | - | - |
| Change | - | - | 26.2% | 22.06% | - | - | - |
| Announcement Date | 30/04/21 | 01/03/23 | 15/05/24 | 13/05/25 | 13/05/26 | - | - |
1EUR in Million
Estimates
Forecast Balance Sheet: AB Science
| Fiscal Period: December | 2020 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - |
| Announcement Date | 30/04/21 | 01/03/23 | 15/05/24 | 13/05/25 | 13/05/26 | - | - |
Estimates
Cash Flow Forecast: AB Science
| Fiscal Period: December | 2023 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| CAPEX 1 | 0.345 | - | - | - |
| Change | - | - | - | - |
| Free Cash Flow (FCF) 1 | -17.22 | -4.571 | -6.4 | -3.6 |
| Change | - | - | -6.67% | 43.75% |
| Announcement Date | 15/05/24 | 13/05/26 | - | - |
1EUR in Million
Estimates
Forecast Financial Ratios: AB Science
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
| EBITDA Margin (%) | - | - | - | - | -1,150.31% | -505.3% | - | - | - |
| EBIT Margin (%) | - | - | - | - | -1,384.43% | -567.53% | 54.43% | -541.67% | -492.31% |
| EBT Margin (%) | - | - | - | - | - | - | - | - | - |
| Net margin (%) | - | - | - | - | -1,035.88% | -730.61% | - | - | - |
| FCF margin (%) | - | - | - | - | -1,774.85% | - | -389.35% | -533.33% | -276.92% |
| FCF / Net Income (%) | - | - | - | - | 171.34% | - | - | - | - |
Profitability | |||||||||
| ROA | -54.29% | -38.87% | -33.87% | -44.16% | -34.02% | -15.62% | - | - | - |
| ROE | 104.08% | 64.88% | 67.67% | 46.26% | 42.29% | 34.99% | - | - | - |
Financial Health | |||||||||
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - | - |
| Debt / Free cash flow | - | - | - | - | - | - | - | - | - |
Capital Intensity | |||||||||
| CAPEX / Current Assets (%) | - | - | - | - | 35.57% | - | - | - | - |
| CAPEX / EBITDA (%) | - | - | - | - | -3.09% | - | - | - | - |
| CAPEX / FCF (%) | - | - | - | - | -2% | - | - | - | - |
Items per share | |||||||||
| Cash flow per share 1 | 0.1293 | 0.3939 | 0.1871 | 0.1559 | 0.1044 | 0.125 | - | - | - |
| Change | - | 204.71% | -52.49% | -16.7% | -33.05% | 19.79% | - | - | - |
| Dividend per Share 1 | - | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - | - |
| Book Value Per Share 1 | -0.6089 | -0.3727 | -0.4978 | -0.7649 | -0.3615 | -0.3718 | - | - | - |
| Change | - | 38.8% | -33.57% | -53.66% | 52.74% | -2.86% | - | - | - |
| EPS 1 | -0.552 | -0.3402 | -0.3044 | -0.29 | -0.2413 | -0.15 | - | - | - |
| Change | - | 38.37% | 10.53% | 4.71% | 16.79% | 37.84% | - | - | - |
| Nbr of stocks (in thousands) | 44,060 | 45,540 | 46,859 | 46,861 | 50,891 | 65,248 | - | - | - |
| Announcement Date | 30/04/20 | 30/04/21 | 01/03/22 | 01/03/23 | 17/05/24 | 27/05/25 | - | - | - |
1EUR
Estimates
| 2025 | 2026 * | |
|---|---|---|
| P/E Ratio | - | - |
| PBR | - | - |
| EV / Sales | 95.4x | 56.6x |
| Yield | - | - |
EPS & Dividend
Y-o-Y evolution of P/E
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AB Stock
- Financials AB Science
Select your edition
All financial news and data tailored to specific country editions
